Report cover image

Dexcel PT Israel Ltd - Strategic SWOT Analysis Review

Publisher GlobalData
Published Feb 28, 2025
Length 24 Pages
SKU # GBDT19677437

Description

Dexcel PT Israel Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights

Dexcel PT Israel Ltd (Dexcel Pharma) develops, manufactures and markets branded and generic pharmaceuticals in various dosage forms. The company's major products include PerioChip (chlorhexidine gluconate), a non-antibiotic adjunct treatment for scaling and root planning and adult periodontitis; Deximune, an immunosuppressant; and omeprazole delayed released tablet for the treatment of gastroesophageal reflux disease, peptic ulcer disease, and Zollinger–Ellison syndrome. It also offers products for cardiovascular disorders, dental diseases, allergies, pain relief, and skin diseases, among others. The company develops formulations using proprietary, patent-protected, drug delivery technologies. It sells its products through a network of subsidiaries and distributors in Western Europe. Dexcel Pharma is headquartered in Or Akiva, Haifa, Israel.

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note:Some sections may be missing if data is unavailable for the company.

Table of Contents

24 Pages
Section 1 - About the Company
Dexcel PT Israel Ltd - Key Facts
Dexcel PT Israel Ltd - Key Employees
Dexcel PT Israel Ltd - Major Products and Services
Dexcel PT Israel Ltd - History
Dexcel PT Israel Ltd - Company Statement
Dexcel PT Israel Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Dexcel PT Israel Ltd - Business Description
Dexcel PT Israel Ltd - SWOT Analysis
SWOT Analysis - Overview
Dexcel PT Israel Ltd - Strengths
Dexcel PT Israel Ltd - Weaknesses
Dexcel PT Israel Ltd - Opportunities
Dexcel PT Israel Ltd - Threats
Dexcel PT Israel Ltd - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Dexcel PT Israel Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
Dexcel PT Israel Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
Dexcel PT Israel Ltd, Recent Deals Summary
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Dexcel PT Israel Ltd, Key Facts
Dexcel PT Israel Ltd, Key Employees
Dexcel PT Israel Ltd, Major Products and Services
Dexcel PT Israel Ltd, History
Dexcel PT Israel Ltd, Other Locations
Dexcel PT Israel Ltd, Subsidiaries
Dexcel PT Israel Ltd, Key Competitors
Dexcel PT Israel Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
Dexcel PT Israel Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
Dexcel PT Israel Ltd, Recent Deals Summary
List of Figures
Dexcel PT Israel Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
Dexcel PT Israel Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2019 to YTD 2025

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us